News Headlines Article

How a failed protein could unleash a new wave of Alzheimer’s research
San Francisco Business Times

A DNA-fixing protein, best known for failing in breast and ovarian cancers, could give drug-development companies and scientists a new avenue for potential treatments for Alzheimer’s disease. In a paper published Monday in the science journal Nature Communications, researchers at the Gladstone Institutes in San Francisco found reduced levels of the BRCA1 protein in the brain correlated with an accumulation of DNA damage.